“…Constitutively activated STAT3 activity has been routinely observed in multiple human cancers including lung, gastric, skin, head and neck, ovarian, breast, colon, and prostate (Bromberg et al, 1999;Bowman et al, 2000;Yu and Jove, 2004;Hsieh et al, 2005;Lin et al, 2005;Yin et al, 2006;Sansone et al, 2007;Abdulghani et al, 2008). In vitro and animal models have shown that inactivation of STAT3 inhibited carcinogenesis and the growth of established tumors, while enhancing expression of this gene promoted tumor incidence and growth (Yu and Jove, 2004;Jing et al, 2006;Siddiquee et al, 2007a,b;Weerasinghe et al, 2007;Bollrath et al, 2009). Moreover, activation of STAT3 has been associated with advanced stages of prostate cancer (Horinaga et al, 2005) and metastatic progression of several different cancer types, including lung cancer (Dauer et al, 2005).…”